Linda Burkly
Chief Tech/Sci/R&D Officer en EDITAS MEDICINE, INC. .
Fortuna: 630 863 $ al 31/03/2024
Perfil
Linda C.
Burkly is currently the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. Prior to her current position, she worked at Biogen, Inc. as the Vice President & Senior Distinguished Investigator from 2014 to 2022.
Burkly received her undergraduate degree from Fairfield University and her doctorate from Tufts University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EDITAS MEDICINE, INC.
0.10% | 02/03/2024 | 85 022 ( 0.10% ) | 630 863 $ | 31/03/2024 |
Cargos activos de Linda Burkly
| Empresas | Cargo | Inicio |
|---|---|---|
| EDITAS MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 24/07/2023 |
Antiguos cargos conocidos de Linda Burkly.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2022 |
Formación de Linda Burkly.
| Fairfield University | Undergraduate Degree |
| Tufts University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Linda Burkly
